Puzanov, Igor J.: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Vemurafenib for BRAF V600–Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis

Diamond, Eli L., Subbiah, Vivek, Lockhart, A. Craig, Blay, Jean-Yves, Puzanov, Igor, Chau, Ian, Raje, Noopur S., Wolf, Jurgen, Erinjeri, Joseph P., Torrisi, Jean, Lacouture, Mario, Elez, Elena, Martín

Journal:

Year:

2017

Language:

english

File:

PDF, 276 KB

english, 2017

2

Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial

Georgina V Long, Uwe Trefzer, Michael A Davies, Richard F Kefford, Paolo A Ascierto, Paul B Chapman, Igor Puzanov, Axel Hauschild, Caroline Robert, Alain Algazi, Laurent Mortier, Hussein Tawbi, Tabea

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 259 KB

english, 2012

3

Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial

Ribas, Antoni, Puzanov, Igor, Dummer, Reinhard, Schadendorf, Dirk, Hamid, Omid, Robert, Caroline, Hodi, F Stephen, Schachter, Jacob, Pavlick, Anna C, Lewis, Karl D, Cranmer, Lee D, Blank, Christian U,

Journal:

The Lancet Oncology

Year:

2015

Language:

english

File:

PDF, 411 KB

english, 2015

4

Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations

Hyman, David M., Puzanov, Igor, Subbiah, Vivek, Faris, Jason E., Chau, Ian, Blay, Jean-Yves, Wolf, Jürgen, Raje, Noopur S., Diamond, Eli L., Hollebecque, Antoine, Gervais, Radj, Elez-Fernandez, Maria

Journal:

New England Journal of Medicine

Year:

2015

Language:

english

File:

PDF, 601 KB

english, 2015

5

Fulminant Myocarditis with Combination Immune Checkpoint Blockade

Johnson, Douglas B., Balko, Justin M., Compton, Margaret L., Chalkias, Spyridon, Gorham, Joshua, Xu, Yaomin, Hicks, Mellissa, Puzanov, Igor, Alexander, Matthew R., Bloomer, Tyler L., Becker, Jason R.,

Journal:

New England Journal of Medicine

Year:

2016

Language:

english

File:

PDF, 1.12 MB

english, 2016

6

Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy

Ribas, Antoni, Dummer, Reinhard, Puzanov, Igor, VanderWalde, Ari, Andtbacka, Robert H.I., Michielin, Olivier, Olszanski, Anthony J., Malvehy, Josep, Cebon, Jonathan, Fernandez, Eugenio, Kirkwood, John

Journal:

Year:

2017

Language:

english

File:

PDF, 4.18 MB

english, 2017

7

Safety and Antitumor Activity of Pembrolizumab in Advanced Programmed Death Ligand 1–Positive Endometrial Cancer

Ott, Patrick A., Bang, Yung-Jue, Berton-Rigaud, Dominique, Elez, Elena, Pishvaian, Michael J., Rugo, Hope S., Puzanov, Igor, Mehnert, Janice M., Aung, Kyaw L., Lopez, Juanita, Carrigan, Marion, Saraf,

Journal:

Obstetric and Gynecologic Survey

Year:

2018

Language:

english

File:

PDF, 78 KB

english, 2018

8

Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy

Ribas, Antoni, Dummer, Reinhard, Puzanov, Igor, VanderWalde, Ari, Andtbacka, Robert H.I., Michielin, Olivier, Olszanski, Anthony J., Malvehy, Josep, Cebon, Jonathan, Fernandez, Eugenio, Kirkwood, John

Journal:

Year:

2018

Language:

english

File:

PDF, 520 KB

english, 2018

9

Intratumoral Immunotherapy—Update 2019

Hamid, Omid, Ismail, Rubina, Puzanov, Igor

Journal:

Year:

2019

Language:

english

File:

PDF, 2.20 MB

english, 2019

10

Initial Geochemical Study of Planned Impact Zones of the Separated Parts of Launch Vehicles by OneWeb Project (Inclination 87Â°, Russia)

Saltykov, Aleksey V., Balykin, Sergey N., Archipov, Igor A., Puzanov, Aleksandr V.

Journal:

Water, Air & Soil Pollution

Year:

2020

File:

PDF, 1.32 MB

2020

11

Pembrolizumab for the treatment of programmed deathâligand 1âpositive advanced carcinoid or pancreatic neuroendocrine tumors: Results from the KEYNOTEâ028 study

Mehnert, Janice M., Bergsland, Emily, OâNeil, Bert H., Santoro, Armando, Schellens, Jan H. M., Cohen, Roger B., Doi, Toshihiko, Ott, Patrick A., Pishvaian, Michael J., Puzanov, Igor, Aung, Kyaw L.,

Journal:

Year:

2020

File:

PDF, 649 KB

2020

12

Combination targeted therapy in advanced renal cell carcinoma

Jeffrey Sosman, Igor Puzanov

Journal:

Year:

2009

Language:

english

File:

PDF, 245 KB

english, 2009

13

Insulin-like growth factor-1 receptor inhibitor, AMG-479, in cetuximab-refractory head and neck squamous cell carcinoma

Christine H. Chung, Paula R. Pohlmann, Mace L. Rothenberg, Brian B. Burkey, Joel Parker, Kevin Palka, Joseph Aulino, Igor Puzanov, Barbara Murphy

Journal:

Year:

2011

Language:

english

File:

PDF, 751 KB

english, 2011

14

Determination of chemically reduced pyrrolobenzodiazepine SJG-136 in human plasma by HPLC-MS/MS: application to an anticancer phase I dose escalation study

M. Wade Calcutt, Wooin Lee, Igor Puzanov, Mace L. Rothenberg, David L. Hachey

Journal:

Journal of Mass Spectrometry

Year:

2008

Language:

english

File:

PDF, 323 KB

english, 2008

15

Alterations in osteoclast morphology following long-term 17beta-estradiol administration in the mouse

Helen E Gruber, Igor J Puzanov, Michael Bennett, Vinay Kumar, Brian Gordon

Journal:

BMC Cell Biology

Year:

2001

Language:

english

File:

PDF, 2.95 MB

english, 2001

16

B-RAF Inhibitors: An Evolving Role in the Therapy of Malignant Melanoma

Cynthia Shepherd, Igor Puzanov, Jeffrey A. Sosman

Journal:

Current Oncology Reports

Year:

2010

Language:

english

File:

PDF, 208 KB

english, 2010

17

Natural killer cell differentiation: insights from knockout and transgenic mouse models and in vitro systems

Noelle Sevilir Williams, Jennifer Klem, Igor J. Puzanov, P. V. Sivakumar, John D. Schatzle, Michael Bennett, Vinay Kumar

Journal:

Immunological Reviews

Year:

1998

Language:

english

File:

PDF, 8.57 MB

english, 1998

18

Vemurafenib (RG67204, PLX4032): a potent, selective BRAF kinase inhibitor

Patrawala, Samit, Puzanov, Igor

Journal:

Future Oncology

Year:

2012

Language:

english

File:

PDF, 1.79 MB

english, 2012

19

Two phase 2 trials of the novel Akt inhibitor perifosine in patients with advanced renal cell carcinoma after progression on vascular endothelial growth factor-targeted therapy

Daniel C. Cho, Thomas E. Hutson, Wolfram Samlowski, Peter Sportelli, Brad Somer, Paul Richards, Jeffrey A. Sosman, Igor Puzanov, M. Dror Michaelson, Keith T. Flaherty, Robert A. Figlin, Nicholas J. Vo

Journal:

Year:

2012

Language:

english

File:

PDF, 201 KB

english, 2012

20

Building on a foundation of VEGF and mTOR targeted agents in renal cell carcinoma

Keith T. Flaherty, Igor Puzanov

Journal:

Biochemical Pharmacology

Year:

2010

Language:

english

File:

PDF, 253 KB

english, 2010

21

Targeted Molecular Therapy in Melanoma

Igor Puzanov, Keith T. Flaherty

Journal:

Seminars in Cutaneous Medicine and Surgery

Year:

2010

Language:

english

File:

PDF, 322 KB

english, 2010

22

Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial

Kim Margolin, Marc S Ernstoff, Omid Hamid, Donald Lawrence, David McDermott, Igor Puzanov, Jedd D Wolchok, Joseph I Clark, Mario Sznol, Theodore F Logan, Jon Richards, Tracy Michener, Agnes Balogh, Ke

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 129 KB

english, 2012

23

Targeted drug development in melanoma and nonsmall cell lung cancer: BRAF, MEK, and ALK inhibitors

Chi, Ming, Puzanov, Igor

Journal:

memo - Magazine of European Medical Oncology

Year:

2012

Language:

english

File:

PDF, 440 KB

english, 2012

24

Biological challenges of BRAF inhibitor therapy

Igor Puzanov, Patrick Burnett, Keith T. Flaherty

Journal:

Molecular Oncology

Year:

2011

Language:

english

File:

PDF, 388 KB

english, 2011

25

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

Flaherty, Keith T., Puzanov, Igor, Kim, Kevin B., Ribas, Antoni, McArthur, Grant A., Sosman, Jeffrey A., O'Dwyer, Peter J., Lee, Richard J., Grippo, Joseph F., Nolop, Keith, Chapman, Paul B.

Journal:

Boston Medical and Surgical Journal

Year:

2010

Language:

english

File:

PDF, 830 KB

english, 2010

26

Recombinant interleukin-21 plus sorafenib for metastatic renal cell carcinoma: a phase 1/2 study

Bhatia, Shailender, Curti, Brendan, Ernstoff, Marc S, Gordon, Michael, Heath, Elisabeth I, Miller, Wilson H, Puzanov, Igor, Quinn, David I, Flaig, Thomas W, VanVeldhuizen, Peter, Byrnes-Blake, Kelly,

Journal:

Journal for ImmunoTherapy of Cancer

Year:

2014

Language:

english

File:

PDF, 365 KB

english, 2014

27

Updated results and correlative FDG-PET analysis of a phase IB study of vemurafenib and cobimetinib (MEK inhibitor [GDC-0973]), in advancedBRAFV600- mutated melanoma (BRIM7)

Puzanov, Igor, McArthur, Grant, Gonzalez, Rene, Pavlick, Anna, Hamid, Omid, Gajewski, Thomas F, Yin, Ming, Fredrickson, Jill, Choong, Nicholas, Ribas, Antoni

Journal:

Journal of Translational Medicine

Year:

2014

Language:

english

File:

PDF, 92 KB

english, 2014

28

Biomarker analysis of on-treatment and at progression biopsies from BRIM7 - a phase 1B trial of combined vemurafenib and cobimetinib treatment in BRAF V600 mutated melanoma

Yan, Yibing, McArthur, Grant, Hamid, Omid, Puzanov, Igor, Gonzalez, Rene, Gajewski, Thomas, Wang, Yulei, Wongchenko, Matthew, Choong, Nicholas, Ribas, Antoni

Journal:

Journal of Translational Medicine

Year:

2014

Language:

english

File:

PDF, 88 KB

english, 2014

29

Phase 1 results of a phase 1b/2, multicenter, open-label trial to evaluate safety and efficacy of talimogene laherparepvec (T-VEC) and ipilimumab (ipi) vs ipi alone in previously untreated, unresected stage IIIB-IV melanoma

Igor Puzanov,Mohammed Milhem,Robert Andtbacka…

Journal:

Journal for ImmunoTherapy of Cancer

Year:

2013

Language:

english

File:

PDF, 80 KB

english, 2013

30

A randomized phase 2 trial of gemcitabine/cisplatin with or without cetuximab in patients with advanced urothelial carcinoma

Hussain, Maha, Daignault, Stephanie, Agarwal, Neeraj, Grivas, Petros D., Siefker-Radtke, Arlene O., Puzanov, Igor, MacVicar, Gary R., Levine, Ellis Glenn, Srinivas, Sandy, Twardowski, Przemyslaw, Eise

Journal:

Year:

2014

Language:

english

File:

PDF, 362 KB

english, 2014

31

Phase 1 trial of tivantinib in combination with sorafenib in adult patients with advanced solid tumors

Puzanov, Igor, Sosman, Jeffrey, Santoro, Armando, Saif, Muhammad W., Goff, Laura, Dy, Grace K., Zucali, Paolo, Means-Powell, Julie A., Ma, Wen Wee, Simonelli, Matteo, Martell, Robert, Chai, Feng, Lama

Journal:

Investigational New Drugs

Year:

2015

Language:

english

File:

PDF, 439 KB

english, 2015

32

Treatment ofNRAS-Mutant Melanoma

Johnson, Douglas B., Puzanov, Igor

Journal:

Current Treatment Options in Oncology

Year:

2015

Language:

english

File:

PDF, 974 KB

english, 2015

33

A randomized controlled comparison of pembrolizumab and chemotherapy in patients with ipilimumab-refractory melanoma

Dummer, Reinhard, Daud, Adil, Puzanov, Igor, Hamid, Omid, Schadendorf, Dirk, Robert, Caroline, Schachter, Jacob, Pavlick, Anna, Gonzalez, Rene, Hodi, F, Cranmer, Lee D, Blank, Christian, O’Day, Steven

Journal:

Journal of Translational Medicine

Year:

2015

Language:

english

File:

PDF, 240 KB

english, 2015

34

Combining targeted and immunotherapy: BRAF inhibitor dabrafenib (D) ± the MEK inhibitor trametinib (T) in combination with ipilimumab (Ipi) for V600E/K mutation-positive unresectable or metastatic melanoma (MM)

Journal:

Journal of Translational Medicine

Year:

2015

Language:

english

File:

PDF, 237 KB

english, 2015

35

Ipilimumab Plus Sargramostim vs Ipilimumab Alone for Treatment of Metastatic Melanoma

Hodi, F. Stephen, Lee, Sandra, McDermott, David F., Rao, Uma N., Butterfield, Lisa H., Tarhini, Ahmad A., Leming, Philip, Puzanov, Igor, Shin, Donghoon, Kirkwood, John M.

Journal:

JAMA The Journal of the American Medical Association

Year:

2014

Language:

english

File:

PDF, 386 KB

english, 2014

36

Long-term outcome in BRAFV600E melanoma patients treated with vemurafenib: Patterns of disease progression and clinical management of limited progression

Puzanov, Igor, Amaravadi, Ravi K., McArthur, Grant A., Flaherty, Keith T., Chapman, Paul B., Sosman, Jeffrey A., Ribas, Antoni, Shackleton, Mark, Hwu, Patrick, Chmielowski, Bartosz, Nolop, Keith B., L

Journal:

European Journal of Cancer

Year:

2015

Language:

english

File:

PDF, 508 KB

english, 2015

37

A Phase II Study of Bevacizumab and High-dose Interleukin-2 in Patients With Metastatic Renal Cell Carcinoma

Dandamudi, Uday B., Ghebremichael, Musie, Sosman, Jeffrey A., Clark, Joseph I., McDermott, David F., Atkins, Michael B., Dutcher, Janice P., Urba, Walter J., Regan, Meredith M., Puzanov, Igor, Crocenz

Journal:

Journal of Immunotherapy

Year:

2013

Language:

english

File:

PDF, 159 KB

english, 2013

38

Talimogene laherparepvec (T-VEC) for the treatment of advanced melanoma

Johnson, Douglas B, Puzanov, Igor, Kelley, Mark C

Journal:

Year:

2015

Language:

english

File:

PDF, 1.81 MB

english, 2015

39

Sunitinib-associated hypertension and neutropenia as efficacy biomarkers in metastatic renal cell carcinoma patients

Donskov, Frede, Michaelson, M Dror, Puzanov, Igor, Davis, Mellar P, Bjarnason, Georg A, Motzer, Robert J, Goldstein, David, Lin, Xun, Cohen, Darrel P, Wiltshire, Robin, Rini, Brian I

Journal:

British Journal of Cancer

Year:

2015

Language:

english

File:

PDF, 556 KB

english, 2015

40

Clinical development of talimogene laherparepvec (T-VEC): a modified herpes simplex virus type-1–derived oncolytic immunotherapy

Harrington, Kevin J., Puzanov, Igor, Hecht, J. Randolph, Hodi, F. Stephen, Szabo, Zsolt, Murugappan, Swami, Kaufman, Howard L.

Journal:

Expert Review of Anticancer Therapy

Year:

2015

Language:

english

File:

PDF, 932 KB

english, 2015

41

Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune Disorders

Johnson, Douglas B., Sullivan, Ryan J., Ott, Patrick A., Carlino, Matteo S., Khushalani, Nikhil I., Ye, Fei, Guminski, Alexander, Puzanov, Igor, Lawrence, Donald P., Buchbinder, Elizabeth I., Mudigond

Journal:

Year:

2015

Language:

english

File:

PDF, 329 KB

english, 2015

42

Anti-CTLA-4 and BRAF inhibition in patients with metastatic melanoma and brain metastases

Puzanov, Igor, Wolchok, Jedd D, Ascierto, Paolo A, Hamid, Omid, Margolin, Kim

Journal:

Expert Review of Dermatology

Year:

2013

Language:

english

File:

PDF, 548 KB

english, 2013

43

Phase 2 Study of Bevacizumab and Temsirolimus After VEGFR TKI in Metastatic Renal Cell Carcinoma

Mahoney, Kathleen M., Jacobus, Susanna, Bhatt, Rupal S., Song, Jiaxi, Carvo, Ingrid, Cheng, Su-Chun, Simpson, Mekailah, Fay, André P., Puzanov, Igor, Michaelson, M. Dror, Atkins, Michael B., McDermott

Journal:

Clinical Genitourinary Cancer

Year:

2016

Language:

english

File:

PDF, 2.23 MB

english, 2016

44

Pembrolizumab for the treatment of advanced melanoma

Burns, Michael C, O’Donnell, Aidan, Puzanov, Igor

Journal:

Expert Opinion on Orphan Drugs

Year:

2016

Language:

english

File:

PDF, 564 KB

english, 2016

45

Treatment of elderly patients with melanoma

Johnpulle, Romany A., Puzanov, Igor, Johnson, Douglas B.

Journal:

memo - Magazine of European Medical Oncology

Year:

2016

Language:

english

File:

PDF, 164 KB

english, 2016

46

Talimogene laherparepvec in advanced melanoma

Pollack, Megan H., Aston, Jonathan, Benrashid, Mona, Johnson, Douglas B., Puzanov, Igor

Journal:

Expert Opinion on Orphan Drugs

Year:

2016

Language:

english

File:

PDF, 874 KB

english, 2016

47

Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial

Andtbacka, Robert H. I., Ross, Merrick, Puzanov, Igor, Milhem, Mohammed, Collichio, Frances, Delman, Keith A., Amatruda, Thomas, Zager, Jonathan S., Cranmer, Lee, Hsueh, Eddy, Chen, Lisa, Shilkrut, Ma

Journal:

Annals of Surgical Oncology

Year:

2016

Language:

english

File:

PDF, 1.62 MB

english, 2016

48

Management of ‘pan-negative’ melanoma: current and emerging strategies

Johnson, Douglas B, Peng, Chengwei, Puzanov, Igor

Journal:

Melanoma Management

Year:

2014

Language:

english

File:

PDF, 1.65 MB

english, 2014

49

Retrospective Analysis of the Safety and Efficacy of Interleukin-2 After Prior VEGF-targeted Therapy in Patients With Advanced Renal Cell Carcinoma

Cho, Daniel C., Puzanov, Igor, Regan, Meredith M., Schwarzberg, Talya, Seery, Virginia, Lee, Mee-Young, Liu, Vivian, Bhatt, Rupal, Koon, Henry, Mier, James W., Sosman, Jeffrey A., Atkins, Michael B.,

Journal:

Journal of Immunotherapy

Year:

2009

Language:

english

File:

PDF, 103 KB

english, 2009

50

Phase I dose-escalation study of cabazitaxel administered in combination with gemcitabine in patients with metastatic or unresectable advanced solid malignancies

Rixe, Olivier, Puzanov, Igor, LoRusso, Patricia M., Cohen, Roger B., Morris, John C., Olowokure, Olugbenga O., Yin, Jian Y., Doroumian, Séverine, Shen, Liji, Olszanski, Anthony J.

Journal:

Anti-Cancer Drugs

Year:

2015

Language:

english

File:

PDF, 265 KB

english, 2015